News

Intranasal Immunization with a Proteosome-Adjuvanted SARS-CoV2 Spike Protein-Based Vaccine is Immunogenic and Efficacious in Mice & Hamsters
March 2, 2022 - BioRxiv

Covid-19 Nasal Vaccine Produces Antibodies, Cuts Viral Load
March 3, 2022 - Science and Enterprise

Oragenics Announces Positive Data on Their Intranasal SARS-CoV-2 Vaccine Candidate in a Posted Preprint Manuscript

March 3, 2022 - Business Wire

IS THE ALZHEIMER’S VACCINE, PROTOLLIN, CLOSE TO BEING A REALITY?
January 10, 2022 - Responsive Home Care

I-Mab Announces First Patient Dosed in U.S. Phase 1 Study of Protollin for the Treatment of Alzheimer's Disease
December 8, 2021 - PR Newswire

FDA OKs Phase 1 Trial of Nasal Spray Immunotherapy Protollin
August 24, 2021 - Alzheimer's News Today